Click Here to Watch Our New Patient Centered Let's Talk SADS Live!

Enrollment for the TaRGET clinical drug trial for eligible patients affected by ARVC/ACM is now active! Click here to learn more.

  • Home
  • About Us
    • Overview
    • History, Vision, Mission, and Goals
    • Board of Directors
    • Medical Advisory Board
  • Community
    • International SADS Community
    • Supporters & Partners
    • About Sudden Cardiac Arrest
  • Resources
    • Information About SADS Conditions
    • Patients & Families
    • School Safety Toolkit
    • Coaches & Educators
    • Healthcare Professionals
  • Research
    • Clinical Trials
    • Research Studies
  • Patient Stories
    • Patient Voices
    • In Memoriam
  • Events
    • Let’s Talk SADS Live
    • Webinars – Expert Insights
    • Fundraisers
  • News
  • Contact Us
Donate Now
  • Home
  • About Us
    • Overview
    • History, Vision, Mission, and Goals
    • Board of Directors
    • Medical Advisory Board
  • Community
    • International SADS Community
    • Supporters & Partners
    • About Sudden Cardiac Arrest
  • Resources
    • Information About SADS Conditions
    • Patients & Families
    • School Safety Toolkit
    • Coaches & Educators
    • Healthcare Professionals
  • Research
    • Clinical Trials
    • Research Studies
  • Patient Stories
    • Patient Voices
    • In Memoriam
  • Events
    • Let’s Talk SADS Live
    • Webinars – Expert Insights
    • Fundraisers
  • News
  • Contact Us
Donate Now

Additional Information on ARVC

John Hopkins

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Program| Johns Hopkins Heart and Vascular Institute (hopkinsmedicine.org)

Nova Scotia Health

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) | Nova Scotia Health (nshealth.ca)

Info on TMEM43

Heart Disease Gene Discovery is still Saving Lives – Genome Atlantic

LTSL Episode 17 ARVC and the Newfoundland Connection

LTSL EP 17 – ARVC and the Newfoundland Connection (youtube.com)

LTSL Episode 11 Navigating ARVC: Expert Insights into Risk Stratification and Emerging Therapies

LTSL EP 11 – Navigating ARVC: Expert insights into risk stratification and emerging therapies (youtube.com)

 

 

 

Looking for more information on SADS and the foundation?

Contact Us Today

Established in 1995, The Canadian Sudden Arrhythmia Death Syndromes (SADS) Foundation, a registered Canadian charity, is the only patient advocacy group in Canada dedicated to supporting families affected by inherited cardiac rhythm disorders.

Our Location

The Canadian SADS Foundation
424 – 207 Bank Street
Ottawa, ON K2P 2N2

Quick Links

  • What is SADS?
  • Community
  • News
  • Donate Now!
  • Contact Us

Publications

LQTS: An Information Booklet for Patients and Their Families Long QT Syndrome in Women Cardiac Channelopathies: An Information Booklet for Patients and Their Families

© 2023 All rights reserved. Designed by Web Sharx

Join Our Social Media Community

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Donate